|04-09-2018 12:16 PM CET - Health & Medicine||
Global Aptamers Market: Analysis of Opportunities Offered by High Growth Economies, Review till 2022
Press release from: Fact.MR
Fact.MR has been actively involved in offering comprehensive research data concerning various topics which are associated to industrial reference and investor utility. This particular research report titled “Aptamers Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” has been added to the wide online database of FACT.MR which discusses the present as well as future market scenario. Readers can access knowledge related to market volume, regional expanse as well as competitive landscape prevailing in the global aptamers market. In order to study development patterns, this smart assessment also focuses on market dynamics, which talks about drivers, restraints and opportunities estimated to influence the concerned market during the period until 2026.
Request For Sample Report @ www.factmr.com/connectus/sample?flag=S&rep_id=173
Aptamers can be generated quickly as compared to antibodies which is a plus point and hence they are used widely in treating diseases. The global aptamers market is expected to witness a probable increase in demand and hence growth which is influenced by factors associated with the aptamer product. The increase in the research and development activities along with increase in the investments in the biotechnological and pharmaceutical companies has driven the use of aptamers and hence the global aptamer market. Other advantages such as technological advancements followed by patent expiration of SELEX (Systematic Evolution of Ligands by Exponential enrichment technology), is likely to boost the growth of the aptamers market on a global scale. The development in aptamers technology has brought more effective, efficient and cost-reduced process for binding larger molecules as compared to antibodies. This is another aspect contributing to the growth of the global aptamers market. Also, the increasing use of aptamers in disease treatment and drug discovery have a significant impact ensuring its growth in a positive direction.
Aptamers are peptide molecules or oligonucleotides which bind to a target lipid, nucleic acid molecules or proteins. They are rapidly generated and applied in the specific detection, inhibition and characterization of proteins. They are used as detecting reagents, can be used as functional proteomic levels with antibodies, can be used as small molecules as well as pharmaceutical leads. They also can be engineered to attain higher affinity to a large number of target groups. Aptamers can be generated much faster than antibodies and hence can be used to cure diseases much faster than antibodies.
According to Fact.MR’s research report on the global aptamers market, the market is anticipated to show a robust growth rate and poised to register a CAGR of 25.5% during the forecasted period of 2017-2022.
Tug of War Between Diagnostics and Research and Developments
The diagnostics segment as well as research and developments segment by application have a tough fight from the growth standpoint. The research and developments segment, however, is anticipated to reflect a good growth rate which is a shade better than the diagnostics segment. North America region is bound to be more lucrative a region for the growth of these segments. The diagnostics segment, however, has a higher market share and it dominates the market. The market share of diagnostics segment is a bit less than two times than that of the research and development segment. It is almost eight times more than the other segment. Moreover, the diagnostics segment is expected to gain a high BPS by the end of 2022. The research and developments segment is poised to grow at a robust CAGR of 26.5% during the forecast period of 2017 to 2022.
Pharmaceutical Companies and CRO Segments to Register Equal growth; Academic and Research Centers to show high pace
The academic and research centers by end user type are growing at a very high rate and poised to show a CAGR of 26.4% during the period of forecast. The pharmaceutical companies and the contract research organization (CRO) segments are expected to grow alongside one another, and are expected to show similar growth rates throughout the period of forecast. The bio-pharmaceutical companies segment shows the highest market share by revenue in 2017, and thereby dominates the global market and also reflects to gain a comparatively high BPS by the end of 2022.
The report also profiles companies that are expected to remain active in the expansion of the global aptamers market through 2022, which include AM Biotech, Aptagen, LLC, Aptamer Sciences, Inc., Aptamer Group, Aptus Biotech, Base Pair Biotechnologies, Inc., NeoVentures Biotechnology Inc., Somalogic, Inc., TriLink BioTechnologies, LLC and Vivonics Inc.
Browse Full Report with TOC @www.factmr.com/report/173/aptamers-market
Table of Content
1. Global Aptamers Market - Executive Summary
2. Global Aptamers Market Overview
2.1.1. Global Aptamers Market Taxonomy
2.1.2. Global Aptamers Market Definition
2.2. Global Aptamers Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Aptamers Market Y-o-Y Growth
2.3. Global Aptamers Market Dynamics
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. List of Distributors
2.9. Key Participants Market Presence (Intensity Map) By Region
3. Global Aptamers Market Analysis and Forecast By Product Type
3.1. Global Aptamers Market Size and Forecast By Product Type, 2012-2022
3.1.1. DNA Aptamers Market Size and Forecast, 2012-2022
184.108.40.206. Revenue (US$ Mn) Comparison, By Region
220.127.116.11. Market Share Comparison, By Region
18.104.22.168. Y-o-Y growth Comparison, By Region
3.1.2. RNA Aptamers Market Size and Forecast, 2012-2022
22.214.171.124. Revenue (US$ Mn) Comparison, By Region
126.96.36.199. Market Share Comparison, By Region
188.8.131.52. Y-o-Y growth Comparison, By Region
Check Discount @ www.factmr.com/connectus/sample?flag=D&rep_id=173
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare Market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852
This release was published on openPR.
News-ID: 1007654 • Views: 103More releases